Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic.
about
A CRISPR toolbox to study virus-host interactionsChallenge of Liquid Stressed Protective Materials and Environmental Persistence of Ebola Virus.Human Adaptation of Ebola Virus during the West African Outbreak.Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture.A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency.Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability.Biochemical Basis for Increased Activity of Ebola Glycoprotein in the 2013-16 Epidemic.Next step in the ongoing arms race between myxoma virus and wild rabbits in Australia is a novel disease phenotype.The Major Envelope Glycoprotein of Murid Herpesvirus 4 Promotes Sexual Transmission.Predicting virus emergence amid evolutionary noise.Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species.Reconciling Pasteur and Darwin to control infectious diseases.Clinical Manifestations and Modes of Death among Patients with Ebola Virus Disease, Monrovia, Liberia, 2014.Timeline of events.Mapping the Evolutionary Potential of RNA Viruses.Host shifts result in parallel genetic changes when viruses evolve in closely related species.Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models.Ebolaviruses: New roles for old proteins.Identification of H209 as Essential for pH 8-Triggered Receptor-Independent Syncytium Formation by S Protein of Mouse Hepatitis Virus A59.CpG island composition differences are a source of gene expression noise indicative of promoter responsiveness.Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loopEbola evolution during the 2013-2016 outbreakAttenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmissionEvolutionary emergence of infectious diseases in heterogeneous host populations
P2860
Q29994612-3A215D70-4351-4685-9E40-9222EC8E0DE7Q33854282-1D52785F-63F1-4935-9B54-973171CBB6A1Q37402042-03455FAA-8A19-42B0-A3F5-06B41982D925Q38603013-C1B8B086-1BC3-42D8-BA37-757DFE1B04F0Q38702384-F2BB39B8-CCA7-4C31-8BAC-A53ADDE74F49Q38715329-62CA33BB-0AA4-4A6A-B57E-EC3DA28F1D1BQ39540578-DB888E3E-7AFA-465F-AF67-16646649676EQ40056179-7501F063-3C23-4F2E-8C39-CF04B71B2387Q40067585-877AD7E8-30B0-45A1-850A-2BE09B26B142Q40083193-48B1A472-F421-49F5-9B99-CEBB3C22DA56Q40235615-93469249-C5EE-4A9F-8BF6-206C30341BECQ42699151-B0C41914-3DF7-4FD7-83C0-DE58B2386A0DQ44106019-14152203-03DE-4807-87C9-D3CB2957418BQ47558244-495D2C08-049A-4901-A252-35F04C2EBD61Q48218442-0EB20D9F-8D1C-4A5E-BEC4-E9D36A0F1176Q50060474-82B6E073-21B5-4A7B-9AEF-93B4E6390B72Q52426491-494BDC3A-53C1-49E7-AE72-1A76FFAC0DEFQ52591749-2BB450FE-8245-46C5-91C4-D02AB3DE58EDQ52591813-98FD2056-4447-47A2-A5BE-022A11131DDAQ54217122-BA0D7294-1CAF-429D-B128-FA6356D1CE87Q54221972-5D68647A-F548-4119-995E-89AF686245E4Q54260411-70087F19-9E41-4F06-9DF0-2035F4D3FE01Q55428125-132B4DDF-D6B5-425C-BDE3-9278E999416AQ57091851-B662874B-1381-447A-B425-DA3EBB4A2CA5Q57277843-54061DC6-661B-4F37-A636-62057737F920Q57477156-9623E7E9-2972-4212-AC98-BCAA56AB3B6DQ58699986-E891E17B-E4CB-43E1-A1D8-28207BB7DC72
P2860
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic.
@en
type
label
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic.
@en
prefLabel
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic.
@en
P2093
P2860
P50
P1433
P1476
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic.
@en
P2093
Aaron E Lin
Alper Kucukural
Elisa Donnard
Manuel Garber
Patrick McDonel
Pyae Phyo Kyawe
Sean M McCauley
P2860
P304
1088-1098.e6
P356
10.1016/J.CELL.2016.10.014
P407
P50
P577
2016-11-01T00:00:00Z